Welcome to our dedicated page for NuSkin Enterprises news (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on NuSkin Enterprises stock.
Nu Skin Enterprises, Inc. (NYSE: NUS) is a global leader in health and beauty, founded 35 years ago. The company excels in creating and distributing innovative consumer products, focusing on beauty and wellness. Nu Skin’s product lines include personal care items under the Nu Skin brand and nutritional supplements marketed under the Pharmanex brand. Operating in more than 50 countries, the firm’s extensive reach reflects its robust international presence.
Nu Skin Enterprises encompasses several companies such as Nu Skin, Groviv, Wasatch Labs, Elevate Health Sciences, and Casepak. This diverse portfolio enables the company to offer a wide range of products and services, from consumer goods to advanced manufacturing and controlled environment agriculture technologies.
In recent developments, Nu Skin has shown a commitment to innovation and growth. In October 2023, the company announced the release of its third quarter financial results, revealing both challenges and growth opportunities. Despite economic hurdles, particularly in Mainland China and the Americas, Nu Skin experienced stabilization and growth in regions like Europe and Africa. The introduction of new products, such as the ageLOC® WellSpa iO™ and an upcoming mental wellness category in 2024, showcases the firm’s dedication to expanding its offerings and driving long-term success.
In November 2023, Nu Skin celebrated the opening of a new manufacturing facility in Shanghai, China, an investment of approximately $55 million. This facility exemplifies the company's commitment to enhancing production capacity and supply chain efficiency, particularly in Asian markets. The plant uses Industry 4.0 standards, featuring smart systems and real-time data analysis, further underlining Nu Skin’s focus on technological advancement and sustainability.
Additionally, in February 2024, Nu Skin introduced the RenuSpa iO, a smart device designed to promote skin health and body confidence. This FDA-cleared device embodies the latest in microcurrent technology, offering personalized beauty and wellness solutions. The Nu Skin Vera® app enhances the user experience by providing real-time data insights and guided tutorials.
Financial Overview: As of the latest updates, Nu Skin’s projected 2023 revenue is between $1.92 and $1.96 billion, with an expected EPS of $(0.10) to $0.05 or adjusted EPS of $1.62 to $1.77, excluding significant charges. The company’s strategic initiatives, including cost management and product portfolio optimization, aim to drive future growth and profitability.
Nu Skin Enterprises (NYSE: NUS) announced a quarterly cash dividend increase to $0.39 per share, payable on March 8, 2023, to shareholders recorded by February 27, 2023. This increase marks the 22nd consecutive year of dividend growth, showcasing the company's commitment to returning value to shareholders. Chief Financial Officer Mark Lawrence emphasized the company's strong financial position and its confidence in its long-term direction.
Nu Skin Enterprises, Inc. (NYSE: NUS) announced it has provided 800 million meals to malnourished children globally through its Nourish the Children initiative since 2002. The initiative enables purchases of VitaMeal, a nutrient-rich food, which is then donated to those in need via third-party charities. The success of this program, highlighted by the company’s executive chairman Steven J. Lund, reflects its significant social impact. Nu Skin continues its commitment to address childhood hunger while promoting its health and wellness products.
Nu Skin Enterprises, Inc. (NYSE: NUS) will announce its fourth quarter and full year 2022 financial results on February 15, 2023, after market closure. A conference call with management for investors will follow at 5 p.m. ET on the same day, discussing recent results and future business initiatives. The recorded webcast of this call will be accessible through the company's investor relations page until March 1, 2023.
Nu Skin Enterprises (NYSE: NUS) announced its involvement in the 76th Annual Scientific Meeting of the Society of Cosmetic Chemists in Los Angeles on December 12, 2022. The event is a key gathering for cosmetic science, featuring over 1,000 attendees. Nu Skin scientists are presenting research on a proprietary blend of green tea and alpha-tocopherol for cellulite visibility, while Vice President Dr. Helen Knaggs moderates a panel on beauty trends. Additionally, Paul Cox, Ph.D., will present a keynote on ethnobotanical drug candidates for neurodegenerative diseases.
Nu Skin Enterprises, Inc. (NYSE: NUS) has announced that its ageLOC® LumiSpa® iO has won the 2022 "New Product of the Year" award from the Business Intelligence Group. This beauty and cleansing device, recognized for its innovative micropulse oscillation technology, connects to the Nu Skin Vera app to enhance personalized skincare experiences. The LumiSpa iO has contributed to Nu Skin's status as the leading brand in beauty device systems for five consecutive years. The awards highlight innovations aiming to transform consumer experiences.
Nu Skin Enterprises (NYSE: NUS) unveiled the ageLOC® LumiSpa® iO, a smart skin treatment and cleansing device, on November 17, 2022, in Provo, Utah. This device features patented micropulse technology, offering personalized skincare options, intelligent coaching, and routine tracking through the Nu Skin Vera app. Users can create customized facial treatments and track their progress, with clinical studies noting user improvements in skin softness (58%), smoothness (47%), brightness (40%), and radiance (34%). The device is designed for daily use and is available now in the U.S.
Nu Skin Enterprises (NUS) reported Q3 2022 revenue of $537.8 million, representing a 16% decline compared to Q3 2021, impacted by foreign exchange losses and macroeconomic conditions. EPS was $(0.51), significantly down from $0.97 in the same quarter last year. Customer numbers fell by 11% to 1.24 million. The company anticipates Q4 revenue in the range of $500 to $550 million and full-year revenue of $2.20 to $2.25 billion. Despite challenges, Nu Skin remains focused on long-term growth strategies.
Nu Skin Enterprises, Inc. (NYSE: NUS) has announced a quarterly cash dividend of $0.385 per share, to be paid on December 7, 2022, to shareholders of record as of November 25, 2022. This action demonstrates the company's commitment to returning value to shareholders while maintaining a focus on its global integrated beauty and wellness business, which operates in approximately 50 markets worldwide. Nu Skin is also committed to sustainability, aiming for reduced and sustainable packaging by 2030.
Nu Skin Enterprises (NYSE: NUS) will release its third quarter financial results on November 2, 2022, after market close. A conference call for investors is scheduled for 5 p.m. ET on the same day, where management will discuss the quarterly performance and upcoming initiatives. The company operates globally with a focus on innovation in beauty and wellness products, backed by over 35 years of scientific research. Nu Skin is also dedicated to sustainability, aiming for reduced packaging by 2030.
FAQ
What is the current stock price of NuSkin Enterprises (NUS)?
What is the market cap of NuSkin Enterprises (NUS)?
What does Nu Skin Enterprises, Inc. do?
When was Nu Skin Enterprises, Inc. founded?
What is the ticker symbol for Nu Skin Enterprises, Inc.?
What were the recent financial results for Nu Skin Enterprises, Inc.?
What is the ageLOC® WellSpa iO™?
What is the significance of the new manufacturing facility in China for Nu Skin?
What is RenuSpa iO?
Who are the members of the Nu Skin Enterprises family?
How does Nu Skin contribute to sustainability?
What is the Nu Skin Vera® app?
